Sio Gene Therapies Inc.
SIOX · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $32,179 | $20,713 | $26,570 | $49,383 |
| - Cash | $46,127 | $49,865 | $54,771 | $63,729 |
| + Debt | $0 | $4 | $2,362 | $2,516 |
| Enterprise Value | -$13,948 | -$29,148 | -$25,839 | -$11,830 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | $0 | -$12,779 |
| % Margin | – | – | – | – |
| Net Income | -$3,418 | -$3,017 | -$8,406 | -$13,324 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.046 | -0.041 | -0.11 | -0.18 |
| % Growth | -13.2% | 62.9% | 38.9% | – |
| Operating Cash Flow | -$4,922 | -$5,083 | -$8,681 | -$17,822 |
| Capital Expenditures | -$290 | -$13 | -$277 | -$359 |
| Free Cash Flow | -$5,212 | -$5,096 | -$8,958 | -$18,181 |